WHO / Faizza Tanggol
HPV vaccination can prevent infections that cause most cervical cancers and is an important part of Samoa’s pathway towards eliminating cervical cancer as a public health problem.
© Credits

Eliminating cervical cancer as a public health problem is within Samoa’s reach

17 November 2026
Reading time:

Imagine a future where cervical cancer no longer poses a major threat to women’s lives. This is a world we can not only imagine, but one that is within our reach. Cervical cancer is largely preventable through vaccination against human papillomavirus (HPV), regular screening to detect changes in the cervix before they develop into cancer, and timely treatment when these changes are found.

However, cervical cancer continues to take a heavy toll. Globally, it is the fifth most commonly diagnosed cancer among women. In 2024, an estimated 604,000 women were diagnosed with the disease, and around 280,000 died from it. The burden is greatest in low- and middle-income countries, where access to HPV vaccination, cervical screening, diagnosis, and treatment remains unequal.

Almost all cervical cancer cases are caused by persistent infection with certain high-risk types of HPV. HPV is common, and most people will be infected at some point in their lives, usually without symptoms. HPV vaccination can prevent many HPV infections before they occur, while cervical screening can identify changes caused by persistent HPV infection before they develop into cancer. Most HPV infections clear naturally, but some persist and cause changes in the cervix that can develop into cancer over time. This process usually takes 15 to 20 years, providing a critical window for screening, early detection, and treatment.

The global roadmap for eliminating cervical cancer as a public health problem is clear. The World Health Organization (WHO) has set three targets to be achieved by 2030: 90% of girls fully vaccinated against HPV by age 15, 70% of women screened using a high-performance test by ages 35 and 45, and 90% of women identified with cervical precancer or cancer receiving appropriate treatment.

In Samoa, cervical cancer remains a public health concern. According to 2024 estimates from the International Agency for Research on Cancer, WHO’s specialized cancer agency, cervical cancer was the sixth most commonly diagnosed cancer among women in Samoa. There has, however, been welcome progress in protecting women and girls. Samoa’s commitment is set out in its cervical cancer elimination strategy and national cancer control policy, which guide the country’s work on prevention, screening, treatment, and care.

Samoa’s Ministry of Health and its partners should be commended for introducing HPV vaccination into the national routine immunization programme. The recent strengthening of cervical cancer screening through Stay MALU, Mobilizing Advocacy for Lifesaving Upscreening is a considerable step forward for advancing cervical cancer elimination in Samoa. The campaign offers screening to women aged 30 to 65 years, helping to identify changes in the cervix before they develop into cancer. Screening is currently provided mainly through the cervical cancer screening clinic at Moto’otua, with periodic outreach activities helping to reach women in other communities. Plans to expand screening through district hospitals will be important to improve access for women across Upolu and Savai’i. More eligible women in Samoa now need to come forward for screening.  Women with abnormal screening results must also receive timely follow-up, diagnosis, and treatment. Each part of this pathway is essential if Samoa is to achieve the global targets.

A large pink sign reading “Prevent Cervical Cancer Screening Clinic” stands beside a fenced compound with a two-storey building and palm trees.
The cervical cancer screening clinic in Moto'otua, Apia, Samoa. Photo © WHO / Faizza Tanggol

Samoa has also made encouraging progress with HPV vaccination. Based on the latest WHO immunization data, HPV vaccination programme coverage among females reached 87% in 2025. Samoa is therefore approaching the global target of fully vaccinating 90% of girls against HPV by age 15.

Experience from Australia and Aotearoa New Zealand shows the difference sustained HPV vaccination can make. Since Australia introduced its national HPV vaccination programme in 2007, HPV prevalence among vaccine-eligible people has fallen by 90%i. In Aotearoa New Zealand, a national studyii found that fully vaccinated people had a markedly lower risk of cervical cancer than those who were unvaccinated.

For Samoa, the priority now is to sustain and build on its high vaccination coverage. This means reaching girls who have not received the vaccine and ensuring that each new group of eligible girls is protected. Parents and caregivers need clear and trusted information, and vaccination services must reach eligible girls wherever they live or attend school.

Vaccination is one part of the pathway towards eliminating cervical cancer as a public health problem. Screening is equally important because HPV vaccination does not protect against every cancer-causing type of HPV, and many women did not have access to the vaccine when they were younger.

At WHO, we recommend HPV vaccination as a priority for girls aged 9 to 14 years, before exposure to the virus. Screening with a high-performance test every five to 10 years is also recommended, beginning at age 30. Women living with HIV should begin screening at age 25 and be screened every three to five years. Women who have received the HPV vaccine should still follow national screening guidance.

To parents and caregivers: when HPV vaccination is offered, give your daughter the opportunity to be protected. Ask questions, speak with a health worker, and make sure she receives the vaccine according to Samoa’s routine immunization schedule.

To our young girls: receiving the HPV vaccine is a safe and important step that can help protect your future health and well-being.

To women aged 30 to 65: do not wait for symptoms. Contact the Ministry of Health or your nearest health facility to find out when and where screening is available through Stay MALU. Encourage your sisters, friends, colleagues, and other eligible women in your family to be screened as well.

Samoa has already begun the journey towards eliminating cervical cancer as a public health problem. As we mark World Cervical Cancer Elimination Day today, 17 November, we should recognize the progress already made while maintaining the effort needed in the years ahead. By protecting our girls, supporting women to be screened, and ensuring timely care for those who need it, we can move closer to a future in which Samoa can prevent many future cases and deaths and move steadily closer to the global elimination target.


i Australian Centre for Disease Control. (2026, May 25). Australia’s HPV vaccine program leads to 90% drop in prevalence, but gaps remain. https://www.cdc.gov.au/newsroom/news-and-articles/australias-hpv-vaccine-program-leads-90-drop-prevalence-gaps-remain

ii Sykes, P., Innes, C., Simcock, B., Lawton, B., & Williman, J. (2025). Realising the promise of HPV vaccination: Data from the national cervical screening and vaccination registers demonstrates the impact of HPV vaccination in Aotearoa New Zealand. Journal of the Royal Society of New Zealand, 55(5), 1271–1283. https://doi.org/10.1080/03036758.2025.2458028

 

Authors

Dr Wendy Snowdon

WHO Representative to Samoa, American Samoa, Cook Islands, Niue and Tokelau